What We Do

Science, unlocked. If cancer is a puzzle, immunotherapy could be the key. To unlock the answers, we study the fundamental science at the intersection of immunology and cancer.
A collaborative force. We bring together the best players from different disciplines – including immunology, oncology, chemistry and engineering – to generate solutions using multiple perspectives.

Speed up science for patients. We support pre-clinical research programs that directly translate to the clinic so that discoveries can more quickly turn into new treatments for patients.
Build new weapons to fight cancer. With our partners, we develop novel treatments such as therapeutic vaccines and cell therapies, from the ground up.

Meet Our Experts

John Connolly, PhD
Chief Scientific Officer

Lacey Padrón, PhD
Head of Informatics

Christine (Chris) Spencer, PhD
Associate Director, Informatics

Christopher Perry
Associate Director, Biospecimen Operations

A New Model to Accelerate Therapies for One of the Deadliest Cancers

Tackling one of the toughest disease sites to unlock the promise of cell and gene therapy in solid tumors

A first-of-its-kind data analysis engine for scientific discovery.

Can we outsmart cancer by learning from the past?

A data-driven approach to metastatic triple negative breast cancer

Improving cancer vaccines and cell therapies for patients through AI.

Can we predict and prevent autoimmune disease?